Literature DB >> 25242859

A3-adenosine receptors: design of selective ligands and therapeutic prospects.

Kenneth A Jacobson1, Hea O Kim1, Suhaib M Siddiqi1, Mark E Olah2, Gary L Stiles2, Dag K J E von Lubitz1.   

Abstract

Year:  1995        PMID： 25242859      PMCID： PMC4167349          DOI： 10.1358/dof.1995.020.07.531583

Source DB:  PubMed          Journal:  Drugs Future        ISSN： 0377-8282            Impact factor:   0.148


× No keyword cloud information.
  44 in total

1.  Role of the second extracellular loop of adenosine receptors in agonist and antagonist binding. Analysis of chimeric A1/A3 adenosine receptors.

Authors:  M E Olah; K A Jacobson; G L Stiles
Journal:  J Biol Chem       Date:  1994-10-07       Impact factor: 5.157

2.  Effect of pertussis toxin treatment on the putative adenosine A3 receptor-mediated hypotensive response in the rat.

Authors:  A M Carruthers; J R Fozard
Journal:  Eur J Pharmacol       Date:  1993-11-30       Impact factor: 4.432

3.  Structure-activity relationships of N6-benzyladenosine-5'-uronamides as A3-selective adenosine agonists.

Authors:  C Gallo-Rodriguez; X D Ji; N Melman; B D Siegman; L H Sanders; J Orlina; B Fischer; Q Pu; M E Olah; P J van Galen
Journal:  J Med Chem       Date:  1994-03-04       Impact factor: 7.446

4.  Adenosine agonists reduce conditioned avoidance responding in the rat.

Authors:  G E Martin; D J Rossi; M F Jarvis
Journal:  Pharmacol Biochem Behav       Date:  1993-08       Impact factor: 3.533

5.  Molecular cloning and characterization of the human A3 adenosine receptor.

Authors:  C A Salvatore; M A Jacobson; H E Taylor; J Linden; R G Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

Review 6.  Adenosine-induced bronchoconstriction and its inhibition by nedocromil sodium.

Authors:  M K Church; S T Holgate
Journal:  J Allergy Clin Immunol       Date:  1993-07       Impact factor: 10.793

7.  Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor.

Authors:  Q Y Zhou; C Li; M E Olah; R A Johnson; G L Stiles; O Civelli
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

8.  Cardiovascular effects of a non-xanthine-selective antagonist of the A1 adenosine receptor in the anaesthetised pig: pharmacological and therapeutic implications.

Authors:  A Sidi; R Wesley; R Barrett; W Rush; L Belardinelli
Journal:  Cardiovasc Res       Date:  1994-05       Impact factor: 10.787

9.  A role for mast cells in adenosine A3 receptor-mediated hypotension in the rat.

Authors:  J P Hannon; H J Pfannkuche; J R Fozard
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

Review 10.  Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential.

Authors:  K A Jacobson; P J van Galen; M Williams
Journal:  J Med Chem       Date:  1992-02-07       Impact factor: 7.446
View more
  30 in total

1.  Adenosine mediates relaxation of human small resistance-like coronary arteries via A2B receptors.

Authors:  B K Kemp; T M Cocks
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

2.  Signaling by extracellular nucleotides and nucleosides.

Authors:  P Illes; K N Klotz; M J Lohse
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2000-11       Impact factor: 3.000

3.  Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells.

Authors:  S Gessi; K Varani; S Merighi; A Morelli; D Ferrari; E Leung; P G Baraldi; G Spalluto; P A Borea
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

4.  A(1)-, A(2A)- and A(3)-subtype adenosine receptors modulate intraocular pressure in the mouse.

Authors:  M Y Avila; R A Stone; M M Civan
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

Review 5.  Introduction to adenosine receptors as therapeutic targets.

Authors:  Kenneth A Jacobson
Journal:  Handb Exp Pharmacol       Date:  2009

6.  Activation of hippocampal adenosine A3 receptors produces a desensitization of A1 receptor-mediated responses in rat hippocampus.

Authors:  T V Dunwiddie; L Diao; H O Kim; J L Jiang; K A Jacobson
Journal:  J Neurosci       Date:  1997-01-15       Impact factor: 6.167

7.  Activation of A3 adenosine receptors on human eosinophils elevates intracellular calcium.

Authors:  Y Kohno; X Ji; S D Mawhorter; M Koshiba; K A Jacobson
Journal:  Blood       Date:  1996-11-01       Impact factor: 22.113

8.  A2B adenosine receptors mediate relaxation of the pig intravesical ureter: adenosine modulation of non adrenergic non cholinergic excitatory neurotransmission.

Authors:  M Hernández; M V Barahona; S Bustamante; A García-Sacristán; L M Orensanz
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

9.  Induction of apoptosis in HL-60 human promyelocytic leukemia cells by adenosine A(3) receptor agonists.

Authors:  Y Kohno; Y Sei; M Koshiba; H O Kim; K A Jacobson
Journal:  Biochem Biophys Res Commun       Date:  1996-02-27       Impact factor: 3.575

10.  RADIOLABELING AND EFFICIENT SYNTHESIS OF TRITIATED 2-CHLORO-N6-(3-IODOBENZYL)ADENOSINE-5'-N-METHYLURON-AMIDE, A POTENT, SELECTIVE A3 ADENOSINE RECEPTOR AGONIST.

Authors:  Hea O Kim; Calvin Hawes; Pat Towers; Kenneth A Jacobson
Journal:  J Labelled Comp Radiopharm       Date:  1996-06-01       Impact factor: 1.921
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.